|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Calcinosis | |||||
| 2 | More general conditions related to this trial | ||||
| Calcium Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| calcitonin | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Calcitonin Gene-Related Peptide | |||||
| Salmon calcitonin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Bone Density Conservation Agents | |||||
| Cardiovascular Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| National Center for Research Resources (NCRR) | |||||
| Children's Memorial Hospital | |||||